Skip to content

Effect of Dry needling on decreasing elbow flexor stiffness in stroke patients

The effect of dry needling on elbow flexor spasticity and corticospinal excitability in patients with chronic stroke: A double-blind, randomized, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230708058719N1
Enrollment
30
Registered
2023-08-02
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic stroke. Cerebral infarction, unspecified

Interventions

Intervention 1: Intervention group: In order to execute the intervention, the patient assumes a supine position. The head is positioned upon the pillow, aligned with the midline. The arms are slightly

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: stroke-induced hemiplegia A minimum of six months have passed since the occurrence of the stroke, indicating a chronic stage of the disease. The degree of spasticity exhibited by the elbow flexor muscles on the affected side, as determined by the Modified Modified Ashworth Scale (MMAS), is a minimum of 1. Age 30-75 Ability to follow instructions

Exclusion criteria

Exclusion criteria: Individuals undergoing other treatments to alleviate spasticity The administration of pharmacological interventions aimed at reducing spasticity Not having any contraindications to using the TMS device, such as a history of seizures, epilepsy (the person themselves or a first-degree family member), a history of head injury or brain injury, metal in the head (outside the mouth) such as surgical clips, cochlear implants, or welded parts, a history of negative reactions to MRI or TMS, a history of brain-related diseases such as MS or brain tumors, a history of fainting, or a history of severe headaches,pregnancy or conception intention within the last three months, Past use of drugs known to reduce the seizure threshold, such as imipramine, amitriptyline, doxepin, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, theophylline, phenytidine, ketamine, gamma hydroxybutyrate, amphetamine, cocaine, and recent use of drugs or alcohol

Design outcomes

Primary

MeasureTime frame
Corticospinal excitability. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: The transcranial magnetic stimulation device is utilized to measure the resting motor threshold in elbow flexor muscles while simultaneously recording the corresponding motor-evoked potential via electromyography.;Spasticity of the elbow flexor muscles. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: Modified Modified Ashworth Scale.

Secondary

MeasureTime frame
The active and passive range of motion of the elbow joint. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: The assessment will be conducted utilizing a goniometry.;Passive resistance force. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: the hand-held dynamometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNoureddin Nakhostin Ansari

Tehran University of Medical Sciences

nakhostin@sina.tums.ac.ir+98 21 7753 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026